NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) HIV/AIDS RADX INNOVATION FUNNEL

国家生物医学成像和生物工程研究所 (NIBIB) HIV/AIDS RADX 创新漏斗

• 批准号: 10708378
• 负责人: VICTORIA HIMARAS
• 金额: $ 29.88万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10708378
• 关键词: AIDS/HIV problem; Clinical; Development; Goals; HIV; Home; National Institute of Biomedical Imaging and Bioengineering; RADx; Resources; Risk; Services; Speed; United States National Institutes of Health; Vendor; base; commercialization; diagnostic technologies; innovation; parallelization; point of care; technology development

Commercialization Center – VentureWell The goal of the Commercialization Center Innovation Funnel for HIV/AIDs is to provide technical, clinical, and commercialization expertise and resources to a RADx Innovation Funnel seeking to accelerate the development of point-of-care and home-based HIV diagnostic technologies. The Commercialization Center is a trans-NIH focused activity that requires professional services support across a range of commercialization domains to NIH translational activities. To support rapid technology development, consultants with specialized domain expertise are needed to assess and mitigate risks at various stages. The vetting and management of professional service consultants and vendors is a critical component of the parallelization effort to speed innovation.

商业中心- VentureWell HIV/AIDS商业化中心创新漏斗的目标是为RADx创新漏斗提供技术，临床和商业化专业知识和资源，以加速护理点和家庭HIV诊断技术的开发。商业化中心是一个跨NIH的重点活动，需要在一系列商业化领域的专业服务支持NIH的翻译活动。为了支持技术的快速发展，需要具有专门领域知识的咨询人来评估和减轻各个阶段的风险。对专业服务顾问和供应商的审查和管理是加速创新的并行化工作的关键组成部分。